This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Gastrointestinal metagenome is the study of the collective genetic material of the microorganisms living in the human gastrointestinal tract. It focuses on the composition and diversity of the microbiota, the metabolic pathways, and the interaction between the microbial population and their host. The human gut microbiota is composed of over 1000 different species and is essential for human health. It plays an important role in digestion, absorption of nutrients, regulation of the immune system, and protection against pathogens. The gastrointestinal metagenome is a rapidly growing field of study that has the potential to provide insight into the mechanistic basis of many diseases. The analysis of the metagenome is providing a better understanding of how the microbial community interacts with its host and its role in health and disease. Investigations into the gut microbiota have identified links between the microbial composition and diseases such as inflammatory bowel disease, obesity, and diabetes. In addition to microbial composition, the microbial metabolic pathways and their interactions with the host are also important. The metagenome can provide a better understanding of the host-microbe metabolic interactions and the role of the microbiota in the development and progression of diseases.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States